已收盘 10-31 16:00:00 美东时间
+0.450
+2.66%
今日重点评级关注:Canaccord Genuity:维持ATAI Life Sciences"买入"评级,目标价从11美元升至14美元;麦格理:维持Cleanspark"跑赢大市"评级,目标价从20美元升至30美元
10-23 10:06
BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $14 to $19.
10-22 20:02
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
10-16 10:43
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
10-14 09:56
JP Morgan analyst Sebastian Sandler maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price target from $14 to $17.
10-13 21:19
TradingKey - 从加密矿商转型为应用数字公司的Applied Digital(APLD.US)最新公布的第一财季业绩表现亮眼,营收强劲增长并远超市场预期,受此消息提振,公司股价在盘后交易时段大幅飙升逾16%。
10-10 03:48
今日重点评级关注:Maxim Group:上调Adial Pharmaceuticals评级至"买入",目标价1.5美元;BTIG:维持Climb Bio"买入"评级,目标价从7美元升至8美元
10-01 20:13
Guggenheim analyst Subbu Nambi initiates coverage on Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy rating and announces Price Target of $20.
09-30 22:16
(来源:动脉新医药) 编者按: 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中,跨国药企始终扮演着关键角色——他们...
08-27 18:33
Sotera Health (NASDAQ:SHC) will release its quarterly earnings report on Friday...
08-07 22:04